| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2017/02/14 | 21 : 02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/09 | 22 : 06 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/06 | 19 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/03 | 04 : 30 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/02 | 07 : 03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/02 | 07 : 02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07 : 27 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/31 | 03 : 56 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/31 | 03 : 51 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/30 | 05 : 18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/30 | 05 : 12 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/30 | 02 : 17 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/29 | 20 : 58 | Business Wire | Nichi-Iko Pharmaceutical Co., Ltd. Announces Results of Tender Offer to Purchase All of the Outstanding Shares of Common Stoc... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/29 | 19 : 17 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/24 | 22 : 23 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/23 | 06 : 51 | PR Newswire (US) | Chemical Financial Set to Join S&P MidCap 400; Supervalu, Shoe Carnival and Eagle Pharmaceuticals to Join S&P SmallCap 600 | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/22 | 19 : 10 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/19 | 05 : 56 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/19 | 05 : 39 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |